

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.60181228 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.55775709 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.55775709 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.34380432 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.34380432 |
| 6 | surfactant homeostasis (GO:0043129) | 5.27483137 |
| 7 | cysteine metabolic process (GO:0006534) | 5.15876867 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.92177124 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.73297825 |
| 10 | lysine metabolic process (GO:0006553) | 4.73076536 |
| 11 | lysine catabolic process (GO:0006554) | 4.73076536 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.67993636 |
| 13 | glyoxylate metabolic process (GO:0046487) | 4.64317405 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.59714678 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.50160810 |
| 16 | drug transmembrane transport (GO:0006855) | 4.47456780 |
| 17 | glutamate secretion (GO:0014047) | 4.42952557 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.41378835 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.41378835 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.41378835 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.34859726 |
| 22 | chemical homeostasis within a tissue (GO:0048875) | 4.30255655 |
| 23 | drug catabolic process (GO:0042737) | 4.29537475 |
| 24 | urate metabolic process (GO:0046415) | 4.26682282 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.19268139 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.17812562 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.17229444 |
| 28 | sodium ion export (GO:0071436) | 4.13183467 |
| 29 | locomotory exploration behavior (GO:0035641) | 4.07656310 |
| 30 | phosphate ion transport (GO:0006817) | 4.06039033 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.02717665 |
| 32 | phosphate ion transmembrane transport (GO:0035435) | 4.01782986 |
| 33 | synaptic vesicle exocytosis (GO:0016079) | 3.98946450 |
| 34 | urea metabolic process (GO:0019627) | 3.97933880 |
| 35 | urea cycle (GO:0000050) | 3.97933880 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91583288 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 3.90301969 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.89970471 |
| 39 | protein carboxylation (GO:0018214) | 3.86099149 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86099149 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.85118970 |
| 42 | exogenous drug catabolic process (GO:0042738) | 3.84782441 |
| 43 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.81814273 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 3.77867873 |
| 45 | vocalization behavior (GO:0071625) | 3.77311677 |
| 46 | glutamate metabolic process (GO:0006536) | 3.74844933 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 3.74517638 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.68038353 |
| 49 | drug transport (GO:0015893) | 3.66259516 |
| 50 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.65593502 |
| 51 | cellular response to nitric oxide (GO:0071732) | 3.65514798 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 3.65043791 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.64252360 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.62812498 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 3.62198839 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.61468879 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.60341023 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.59719461 |
| 59 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.58139909 |
| 60 | exploration behavior (GO:0035640) | 3.55245275 |
| 61 | neuronal ion channel clustering (GO:0045161) | 3.55094303 |
| 62 | bile acid metabolic process (GO:0008206) | 3.53579685 |
| 63 | aromatic amino acid family metabolic process (GO:0009072) | 3.51645190 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.48929917 |
| 65 | ethanol oxidation (GO:0006069) | 3.46295461 |
| 66 | regulation of protein activation cascade (GO:2000257) | 3.45321505 |
| 67 | cellular sodium ion homeostasis (GO:0006883) | 3.44225572 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.44078499 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 3.43952675 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.43520646 |
| 71 | alpha-amino acid catabolic process (GO:1901606) | 3.41705281 |
| 72 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.39395383 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.37196408 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 3.35004557 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.35004557 |
| 76 | postsynaptic membrane organization (GO:0001941) | 3.34972560 |
| 77 | ketone body metabolic process (GO:1902224) | 3.33975397 |
| 78 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.33906631 |
| 79 | cell migration in hindbrain (GO:0021535) | 3.30369785 |
| 80 | neurotransmitter secretion (GO:0007269) | 3.30340516 |
| 81 | L-amino acid import (GO:0043092) | 3.30164817 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 3.29515717 |
| 83 | tyrosine metabolic process (GO:0006570) | 3.28939950 |
| 84 | phospholipid homeostasis (GO:0055091) | 3.28557629 |
| 85 | cellular amino acid catabolic process (GO:0009063) | 3.28414778 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.26569663 |
| 87 | regulation of complement activation (GO:0030449) | 3.26262349 |
| 88 | regulation of fibrinolysis (GO:0051917) | 3.26200560 |
| 89 | auditory behavior (GO:0031223) | 3.26181807 |
| 90 | response to mercury ion (GO:0046689) | 3.25481161 |
| 91 | regulation of synapse structural plasticity (GO:0051823) | 3.25430717 |
| 92 | fatty acid beta-oxidation (GO:0006635) | 3.25289912 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.24654761 |
| 94 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.24395369 |
| 95 | reverse cholesterol transport (GO:0043691) | 3.19932665 |
| 96 | dendritic spine organization (GO:0097061) | 3.19561212 |
| 97 | fatty acid oxidation (GO:0019395) | 3.18752910 |
| 98 | cholesterol efflux (GO:0033344) | 3.18427570 |
| 99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16421330 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 3.14398405 |
| 101 | neuromuscular process controlling balance (GO:0050885) | 3.14397606 |
| 102 | lipid oxidation (GO:0034440) | 3.13766699 |
| 103 | mating behavior (GO:0007617) | 3.12601487 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.11341011 |
| 105 | benzene-containing compound metabolic process (GO:0042537) | 3.09577579 |
| 106 | amino acid import (GO:0043090) | 3.08341242 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.07764934 |
| 108 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.06715504 |
| 109 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06478743 |
| 110 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06008132 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 3.05256187 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 3.01648658 |
| 113 | fatty acid catabolic process (GO:0009062) | 3.00915689 |
| 114 | coenzyme catabolic process (GO:0009109) | 3.00644433 |
| 115 | plasma lipoprotein particle clearance (GO:0034381) | 3.00420827 |
| 116 | regulation of triglyceride catabolic process (GO:0010896) | 3.00046199 |
| 117 | organic acid catabolic process (GO:0016054) | 2.98563131 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 2.98563131 |
| 119 | triglyceride homeostasis (GO:0070328) | 2.97823932 |
| 120 | acylglycerol homeostasis (GO:0055090) | 2.97823932 |
| 121 | sodium-independent organic anion transport (GO:0043252) | 2.97674107 |
| 122 | cellular glucuronidation (GO:0052695) | 2.97667279 |
| 123 | neuron cell-cell adhesion (GO:0007158) | 2.97460579 |
| 124 | protein-lipid complex remodeling (GO:0034368) | 2.96870325 |
| 125 | macromolecular complex remodeling (GO:0034367) | 2.96870325 |
| 126 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96870325 |
| 127 | regulation of synapse maturation (GO:0090128) | 2.95916655 |
| 128 | phospholipid efflux (GO:0033700) | 2.95400493 |
| 129 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.94186397 |
| 130 | valine metabolic process (GO:0006573) | 2.93306772 |
| 131 | drug metabolic process (GO:0017144) | 2.92725514 |
| 132 | bile acid and bile salt transport (GO:0015721) | 2.92413793 |
| 133 | regulation of ARF protein signal transduction (GO:0032012) | 2.91842663 |
| 134 | semaphorin-plexin signaling pathway (GO:0071526) | 2.91279360 |
| 135 | tricarboxylic acid metabolic process (GO:0072350) | 2.89400925 |
| 136 | respiratory gaseous exchange (GO:0007585) | 2.87405729 |
| 137 | very long-chain fatty acid metabolic process (GO:0000038) | 2.86919899 |
| 138 | cell communication by electrical coupling (GO:0010644) | 2.86378906 |
| 139 | activation of protein kinase A activity (GO:0034199) | 2.86325653 |
| 140 | cerebellar Purkinje cell layer development (GO:0021680) | 2.85920299 |
| 141 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.85801130 |
| 142 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.83878775 |
| 143 | carnitine metabolic process (GO:0009437) | 2.82544995 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 2.80965631 |
| 145 | cellular biogenic amine catabolic process (GO:0042402) | 2.78959702 |
| 146 | amine catabolic process (GO:0009310) | 2.78959702 |
| 147 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.76403184 |
| 148 | establishment of nucleus localization (GO:0040023) | 2.76387383 |
| 149 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.76028542 |
| 150 | positive regulation of lipid catabolic process (GO:0050996) | 2.75841489 |
| 151 | glucuronate metabolic process (GO:0019585) | 2.75707128 |
| 152 | regulation of synaptic plasticity (GO:0048167) | 2.73273058 |
| 153 | synaptic vesicle endocytosis (GO:0048488) | 2.71358685 |
| 154 | potassium ion homeostasis (GO:0055075) | 2.69370974 |
| 155 | neuron recognition (GO:0008038) | 2.68679635 |
| 156 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.65816496 |
| 157 | neuron remodeling (GO:0016322) | 2.65647453 |
| 158 | long-term memory (GO:0007616) | 2.65495616 |
| 159 | axonal fasciculation (GO:0007413) | 2.64351828 |
| 160 | cellular response to reactive nitrogen species (GO:1902170) | 2.63752912 |
| 161 | neurotransmitter transport (GO:0006836) | 2.63617372 |
| 162 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.61304439 |
| 163 | endothelial cell chemotaxis (GO:0035767) | 2.60980885 |
| 164 | response to auditory stimulus (GO:0010996) | 2.60474633 |
| 165 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.59022228 |
| 166 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.58093865 |
| 167 | response to nitric oxide (GO:0071731) | 2.56589654 |
| 168 | synaptic transmission, glutamatergic (GO:0035249) | 2.56310504 |
| 169 | apical protein localization (GO:0045176) | 2.55520495 |
| 170 | neuromuscular junction development (GO:0007528) | 2.55235674 |
| 171 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.52958534 |
| 172 | synapse assembly (GO:0007416) | 2.52869610 |
| 173 | axon ensheathment in central nervous system (GO:0032291) | 2.51903888 |
| 174 | central nervous system myelination (GO:0022010) | 2.51903888 |
| 175 | camera-type eye morphogenesis (GO:0048593) | 2.50728547 |
| 176 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50336394 |
| 177 | regulation of neurotransmitter secretion (GO:0046928) | 2.50044282 |
| 178 | dopamine receptor signaling pathway (GO:0007212) | 2.48865305 |
| 179 | protein localization to endosome (GO:0036010) | 2.47851692 |
| 180 | peripheral nervous system axon ensheathment (GO:0032292) | 2.47836869 |
| 181 | myelination in peripheral nervous system (GO:0022011) | 2.47836869 |
| 182 | potassium ion import (GO:0010107) | 2.46432381 |
| 183 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.46212214 |
| 184 | positive regulation of membrane potential (GO:0045838) | 2.45927595 |
| 185 | mechanosensory behavior (GO:0007638) | 2.45039502 |
| 186 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.44198338 |
| 187 | membrane assembly (GO:0071709) | 2.42790781 |
| 188 | regulation of vesicle fusion (GO:0031338) | 2.40984649 |
| 189 | cellular response to monoamine stimulus (GO:0071868) | 2.40895593 |
| 190 | cellular response to catecholamine stimulus (GO:0071870) | 2.40895593 |
| 191 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.40464608 |
| 192 | regulation of neurotransmitter levels (GO:0001505) | 2.40228095 |
| 193 | innervation (GO:0060384) | 2.39545632 |
| 194 | negative regulation of catenin import into nucleus (GO:0035414) | 2.39201764 |
| 195 | positive regulation of dendrite development (GO:1900006) | 2.39045662 |
| 196 | synapse organization (GO:0050808) | 2.37852197 |
| 197 | regulation of postsynaptic membrane potential (GO:0060078) | 2.36716893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.90062977 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.15702818 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38052280 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31399332 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.90520679 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.44901137 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.27833272 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.03830617 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.01754116 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.74389819 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.40462707 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.29152381 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28349819 |
| 14 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19354953 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.15412763 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.13541692 |
| 17 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10995114 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06723648 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97034024 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.91890104 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87072063 |
| 22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.85978831 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77435915 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70261250 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67018649 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64855452 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64680692 |
| 28 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.64580936 |
| 29 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.61266237 |
| 30 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.60024385 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58222920 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58187696 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55033940 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54137093 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50842430 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48703543 |
| 37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.47835872 |
| 38 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.38755709 |
| 39 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.37920288 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37828723 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36592324 |
| 42 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.35978966 |
| 43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.35871953 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35635882 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33541960 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33093703 |
| 47 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31183980 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27886614 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27783509 |
| 50 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26740548 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25559524 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22311843 |
| 53 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21446477 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21227443 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20725257 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20673839 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19887409 |
| 58 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19790273 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19531921 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17861697 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17251109 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16318479 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14761702 |
| 64 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14708112 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14544684 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13556326 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11964901 |
| 68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11959161 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11460221 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11189459 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10560564 |
| 72 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10448513 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09605404 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08513877 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08253836 |
| 76 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07932936 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07920054 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07817291 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06036693 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05636223 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05413408 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04695491 |
| 83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03585810 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03322761 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02714490 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01913992 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01841168 |
| 88 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01772687 |
| 89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01405258 |
| 90 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00960346 |
| 91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00524998 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00240425 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99871864 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99518059 |
| 95 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98749005 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98721759 |
| 97 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97769656 |
| 98 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97659314 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97057657 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96914166 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96493537 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96185724 |
| 103 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.95317557 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95043774 |
| 105 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93228143 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92725099 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92347194 |
| 108 | AR_19668381_ChIP-Seq_PC3_Human | 0.91812867 |
| 109 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88960382 |
| 110 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87641946 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87516259 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87458718 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86452816 |
| 114 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85925142 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85691297 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84905822 |
| 117 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84409242 |
| 118 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84409242 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83908940 |
| 120 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82928337 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82863616 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82863616 |
| 123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82467745 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81942104 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81708975 |
| 126 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81586147 |
| 127 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81586147 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81192740 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80907862 |
| 130 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80147614 |
| 131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79941376 |
| 132 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77849337 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76101797 |
| 134 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.75758060 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75187233 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74877307 |
| 137 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.73914012 |
| 138 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73611326 |
| 139 | RXR_22108803_ChIP-Seq_LS180_Human | 0.72648690 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72545937 |
| 141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.71984564 |
| 142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70171601 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70069948 |
| 144 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.69218482 |
| 145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68983947 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68934914 |
| 147 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68690547 |
| 148 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68671817 |
| 149 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68301684 |
| 150 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.67368176 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67344649 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67331603 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66745991 |
| 154 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.66657428 |
| 155 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66345677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.68476252 |
| 2 | MP0005360_urolithiasis | 6.36385782 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.75123972 |
| 4 | MP0005365_abnormal_bile_salt | 4.54752340 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09821179 |
| 6 | MP0005083_abnormal_biliary_tract | 3.77367468 |
| 7 | MP0004270_analgesia | 3.39761478 |
| 8 | MP0003252_abnormal_bile_duct | 3.15113928 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.07909721 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.91553736 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.90135726 |
| 12 | MP0005332_abnormal_amino_acid | 2.86417764 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.76907605 |
| 14 | MP0003880_abnormal_central_pattern | 2.69725851 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.67036082 |
| 16 | MP0009840_abnormal_foam_cell | 2.46418825 |
| 17 | MP0003195_calcinosis | 2.46140780 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.45059046 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.44238369 |
| 20 | * MP0004782_abnormal_surfactant_physiolog | 2.36332093 |
| 21 | MP0002064_seizures | 2.33774571 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.33533388 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.25233253 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.19231604 |
| 25 | MP0001958_emphysema | 2.06413795 |
| 26 | * MP0002118_abnormal_lipid_homeostasis | 1.99809174 |
| 27 | MP0009745_abnormal_behavioral_response | 1.99207940 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.99012777 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.92912274 |
| 30 | MP0001486_abnormal_startle_reflex | 1.92277595 |
| 31 | MP0004043_abnormal_pH_regulation | 1.89491092 |
| 32 | MP0000778_abnormal_nervous_system | 1.86727333 |
| 33 | MP0002272_abnormal_nervous_system | 1.82923239 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.75709975 |
| 35 | MP0005409_darkened_coat_color | 1.73609362 |
| 36 | MP0003879_abnormal_hair_cell | 1.72348883 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.68961082 |
| 38 | MP0000609_abnormal_liver_physiology | 1.65069244 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.64748013 |
| 40 | MP0003329_amyloid_beta_deposits | 1.63605263 |
| 41 | MP0009046_muscle_twitch | 1.61737622 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.60258044 |
| 43 | MP0000604_amyloidosis | 1.57855737 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.57616507 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.57129648 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52440846 |
| 47 | MP0001756_abnormal_urination | 1.49269808 |
| 48 | MP0003634_abnormal_glial_cell | 1.48936962 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.46047976 |
| 50 | MP0001970_abnormal_pain_threshold | 1.45358023 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.44669260 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.44338079 |
| 53 | MP0008569_lethality_at_weaning | 1.43464733 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.41130748 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.40744869 |
| 56 | MP0000566_synostosis | 1.40332177 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.39111795 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.36843122 |
| 59 | MP0000955_abnormal_spinal_cord | 1.35269342 |
| 60 | MP0002184_abnormal_innervation | 1.35122751 |
| 61 | MP0000920_abnormal_myelination | 1.34832431 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.28895717 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.28704137 |
| 64 | MP0003123_paternal_imprinting | 1.27626284 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.25422046 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.24992042 |
| 67 | MP0003868_abnormal_feces_composition | 1.24899265 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.20958882 |
| 69 | MP0002136_abnormal_kidney_physiology | 1.20058293 |
| 70 | MP0000681_abnormal_thyroid_gland | 1.19654288 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 1.19171172 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.17265522 |
| 73 | MP0003091_abnormal_cell_migration | 1.16959878 |
| 74 | MP0000534_abnormal_ureter_morphology | 1.16186310 |
| 75 | MP0008004_abnormal_stomach_pH | 1.15220557 |
| 76 | MP0005646_abnormal_pituitary_gland | 1.14614217 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.14239495 |
| 78 | MP0004130_abnormal_muscle_cell | 1.09016619 |
| 79 | * MP0002066_abnormal_motor_capabilities/c | 1.08870436 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.08697845 |
| 81 | MP0003632_abnormal_nervous_system | 1.08490418 |
| 82 | MP0002909_abnormal_adrenal_gland | 1.08169467 |
| 83 | MP0003690_abnormal_glial_cell | 1.06397647 |
| 84 | MP0002152_abnormal_brain_morphology | 1.05918231 |
| 85 | MP0003724_increased_susceptibility_to | 1.03719909 |
| 86 | MP0003283_abnormal_digestive_organ | 1.01512416 |
| 87 | MP0000462_abnormal_digestive_system | 1.01335166 |
| 88 | MP0003631_nervous_system_phenotype | 1.01197861 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.99618727 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.99213242 |
| 91 | MP0009764_decreased_sensitivity_to | 0.98182960 |
| 92 | MP0004858_abnormal_nervous_system | 0.95741242 |
| 93 | MP0003075_altered_response_to | 0.93874505 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.92234895 |
| 95 | MP0002736_abnormal_nociception_after | 0.92104643 |
| 96 | MP0006138_congestive_heart_failure | 0.92046987 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.90840868 |
| 98 | MP0005535_abnormal_body_temperature | 0.90477676 |
| 99 | MP0004885_abnormal_endolymph | 0.89867369 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.88284576 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.87732983 |
| 102 | * MP0001943_abnormal_respiration | 0.86720921 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.86555536 |
| 104 | * MP0001177_atelectasis | 0.86496876 |
| 105 | MP0001984_abnormal_olfaction | 0.86007368 |
| 106 | MP0005647_abnormal_sex_gland | 0.85134757 |
| 107 | MP0003122_maternal_imprinting | 0.85063629 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.84650400 |
| 109 | MP0003942_abnormal_urinary_system | 0.84366109 |
| 110 | MP0008995_early_reproductive_senescence | 0.83882186 |
| 111 | MP0005166_decreased_susceptibility_to | 0.82432602 |
| 112 | MP0004924_abnormal_behavior | 0.81517209 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.81517209 |
| 114 | * MP0009642_abnormal_blood_homeostasis | 0.81456021 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.81389857 |
| 116 | MP0002928_abnormal_bile_duct | 0.80787744 |
| 117 | MP0002168_other_aberrant_phenotype | 0.80301476 |
| 118 | MP0001764_abnormal_homeostasis | 0.79718795 |
| 119 | MP0000579_abnormal_nail_morphology | 0.79323336 |
| 120 | MP0000598_abnormal_liver_morphology | 0.77368795 |
| 121 | MP0005451_abnormal_body_composition | 0.77233988 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.76928020 |
| 123 | MP0000383_abnormal_hair_follicle | 0.76704140 |
| 124 | MP0002229_neurodegeneration | 0.74201134 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.73987226 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.73557536 |
| 127 | MP0003861_abnormal_nervous_system | 0.73423882 |
| 128 | MP0004085_abnormal_heartbeat | 0.72384377 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.70689077 |
| 130 | MP0010678_abnormal_skin_adnexa | 0.70370084 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.70019229 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.69307896 |
| 133 | MP0000751_myopathy | 0.68477062 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.68051278 |
| 135 | MP0001849_ear_inflammation | 0.67914837 |
| 136 | MP0005408_hypopigmentation | 0.67371136 |
| 137 | MP0008469_abnormal_protein_level | 0.66436318 |
| 138 | MP0004272_abnormal_basement_membrane | 0.65925564 |
| 139 | MP0005334_abnormal_fat_pad | 0.65770896 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.65744746 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.65557131 |
| 142 | MP0001963_abnormal_hearing_physiology | 0.65475076 |
| 143 | MP0000538_abnormal_urinary_bladder | 0.63785993 |
| 144 | MP0000026_abnormal_inner_ear | 0.63224524 |
| 145 | MP0002796_impaired_skin_barrier | 0.62563768 |
| 146 | MP0004742_abnormal_vestibular_system | 0.62424873 |
| 147 | MP0008874_decreased_physiological_sensi | 0.61940505 |
| 148 | MP0002896_abnormal_bone_mineralization | 0.61828120 |
| 149 | * MP0002295_abnormal_pulmonary_circulatio | 0.61764603 |
| 150 | MP0005670_abnormal_white_adipose | 0.60605280 |
| 151 | * MP0002133_abnormal_respiratory_system | 0.59711577 |
| 152 | * MP0005388_respiratory_system_phenotype | 0.59711577 |
| 153 | MP0002752_abnormal_somatic_nervous | 0.58934574 |
| 154 | MP0003186_abnormal_redox_activity | 0.58468142 |
| 155 | MP0003953_abnormal_hormone_level | 0.58398760 |
| 156 | MP0002254_reproductive_system_inflammat | 0.58130629 |
| 157 | MP0002971_abnormal_brown_adipose | 0.55715715 |
| 158 | MP0004264_abnormal_extraembryonic_tissu | 0.53726385 |
| 159 | MP0000639_abnormal_adrenal_gland | 0.53178807 |
| 160 | MP0002135_abnormal_kidney_morphology | 0.52746539 |
| 161 | MP0003633_abnormal_nervous_system | 0.50871626 |
| 162 | MP0005448_abnormal_energy_balance | 0.49556439 |
| 163 | MP0004859_abnormal_synaptic_plasticity | 0.49373432 |
| 164 | MP0001664_abnormal_digestion | 0.49060811 |
| 165 | MP0009765_abnormal_xenobiotic_induced | 0.48464297 |
| 166 | MP0004185_abnormal_adipocyte_glucose | 0.48157353 |
| 167 | MP0009763_increased_sensitivity_to | 0.47095065 |
| 168 | MP0002822_catalepsy | 0.46706805 |
| 169 | MP0001944_abnormal_pancreas_morphology | 0.46204885 |
| 170 | MP0003303_peritoneal_inflammation | 0.44512539 |
| 171 | MP0001440_abnormal_grooming_behavior | 0.43996027 |
| 172 | MP0005375_adipose_tissue_phenotype | 0.43297775 |
| 173 | MP0005595_abnormal_vascular_smooth | 0.42879638 |
| 174 | MP0000537_abnormal_urethra_morphology | 0.42325046 |
| 175 | MP0005464_abnormal_platelet_physiology | 0.40869686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 5.73306986 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.07045089 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.81530854 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.53064545 |
| 5 | Xanthomatosis (HP:0000991) | 4.38490178 |
| 6 | Myokymia (HP:0002411) | 4.34113435 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 4.32477080 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.13431537 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97068008 |
| 10 | Abnormality of purine metabolism (HP:0004352) | 3.85065212 |
| 11 | Ketosis (HP:0001946) | 3.83194611 |
| 12 | Obstructive sleep apnea (HP:0002870) | 3.80353078 |
| 13 | Hyperglycinuria (HP:0003108) | 3.77767633 |
| 14 | Complement deficiency (HP:0004431) | 3.72644725 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 3.53428581 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.47223078 |
| 17 | Ketoacidosis (HP:0001993) | 3.43260084 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.42597633 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.42597633 |
| 20 | Ankle clonus (HP:0011448) | 3.39198639 |
| 21 | Increased purine levels (HP:0004368) | 3.35548054 |
| 22 | Hyperuricemia (HP:0002149) | 3.35548054 |
| 23 | Action tremor (HP:0002345) | 3.31948261 |
| 24 | Hyperglycinemia (HP:0002154) | 3.30063331 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 3.27576382 |
| 26 | Focal motor seizures (HP:0011153) | 3.26168669 |
| 27 | Hyperammonemia (HP:0001987) | 3.26045784 |
| 28 | Joint hemorrhage (HP:0005261) | 3.24670238 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.17545494 |
| 30 | Tubulointerstitial fibrosis (HP:0005576) | 3.12429779 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11837802 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.11726952 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10146380 |
| 34 | Abnormality of chloride homeostasis (HP:0011422) | 3.06510597 |
| 35 | Renal salt wasting (HP:0000127) | 3.03311899 |
| 36 | Cerebral aneurysm (HP:0004944) | 3.00018943 |
| 37 | Hyperacusis (HP:0010780) | 2.99903477 |
| 38 | Focal seizures (HP:0007359) | 2.99485234 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.96521862 |
| 40 | Neurofibrillary tangles (HP:0002185) | 2.92708244 |
| 41 | Alkalosis (HP:0001948) | 2.92189504 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.89855651 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.89083660 |
| 44 | Increased circulating renin level (HP:0000848) | 2.88814518 |
| 45 | Epidermoid cyst (HP:0200040) | 2.84243052 |
| 46 | * Interstitial pulmonary disease (HP:0006530) | 2.83639028 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76475865 |
| 48 | Bronchomalacia (HP:0002780) | 2.69154965 |
| 49 | Vascular calcification (HP:0004934) | 2.67717609 |
| 50 | Aplasia involving bones of the extremities (HP:0009825) | 2.66782253 |
| 51 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.66782253 |
| 52 | Aplasia of the phalanges of the hand (HP:0009802) | 2.66782253 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.63560758 |
| 54 | Abnormality of renal excretion (HP:0011036) | 2.61523189 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.59829608 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.59156030 |
| 57 | Fat malabsorption (HP:0002630) | 2.59017631 |
| 58 | Sensorimotor neuropathy (HP:0007141) | 2.58129465 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54846168 |
| 60 | Abnormality of complement system (HP:0005339) | 2.54510150 |
| 61 | Rapidly progressive (HP:0003678) | 2.53348355 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.52757193 |
| 63 | Abnormality of renin-angiotensin system (HP:0000847) | 2.52723097 |
| 64 | Insomnia (HP:0100785) | 2.51621256 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.51018901 |
| 66 | Epileptic encephalopathy (HP:0200134) | 2.50883244 |
| 67 | Spastic gait (HP:0002064) | 2.50185419 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.49318116 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.47152011 |
| 70 | Annular pancreas (HP:0001734) | 2.46848196 |
| 71 | Growth hormone excess (HP:0000845) | 2.44552865 |
| 72 | * Tachypnea (HP:0002789) | 2.44063912 |
| 73 | Hyperaldosteronism (HP:0000859) | 2.39156187 |
| 74 | Esophageal varix (HP:0002040) | 2.38865156 |
| 75 | Malnutrition (HP:0004395) | 2.37483653 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.37392943 |
| 77 | Febrile seizures (HP:0002373) | 2.36632307 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.35330952 |
| 79 | Metabolic acidosis (HP:0001942) | 2.34614774 |
| 80 | Abnormal urine output (HP:0012590) | 2.33954757 |
| 81 | Hypomagnesemia (HP:0002917) | 2.32852009 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.32318210 |
| 83 | Macroorchidism (HP:0000053) | 2.30962657 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.30589291 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.30589291 |
| 86 | Truncal ataxia (HP:0002078) | 2.30344952 |
| 87 | Polycythemia (HP:0001901) | 2.29915417 |
| 88 | Intention tremor (HP:0002080) | 2.29794253 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.29633594 |
| 90 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.29491906 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.28786188 |
| 92 | Lower limb amyotrophy (HP:0007210) | 2.24920745 |
| 93 | Akinesia (HP:0002304) | 2.23359638 |
| 94 | Glomerulosclerosis (HP:0000096) | 2.20395471 |
| 95 | Shallow orbits (HP:0000586) | 2.19124091 |
| 96 | Atonic seizures (HP:0010819) | 2.17585690 |
| 97 | Nephrolithiasis (HP:0000787) | 2.16019595 |
| 98 | Depression (HP:0000716) | 2.14907135 |
| 99 | Hammertoe (HP:0001765) | 2.14844773 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.12738545 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.11963937 |
| 102 | Spastic diplegia (HP:0001264) | 2.11597075 |
| 103 | Potter facies (HP:0002009) | 2.09858233 |
| 104 | Facial shape deformation (HP:0011334) | 2.09858233 |
| 105 | Polyuria (HP:0000103) | 2.09607502 |
| 106 | Pointed chin (HP:0000307) | 2.08876732 |
| 107 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08459738 |
| 108 | Turricephaly (HP:0000262) | 2.08458444 |
| 109 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.08263419 |
| 110 | Hypercortisolism (HP:0001578) | 2.07044836 |
| 111 | Mitral stenosis (HP:0001718) | 2.06049515 |
| 112 | Visceral angiomatosis (HP:0100761) | 2.05649815 |
| 113 | Late onset (HP:0003584) | 2.05247330 |
| 114 | Diplopia (HP:0000651) | 2.04095390 |
| 115 | Abnormality of binocular vision (HP:0011514) | 2.04095390 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 2.03786449 |
| 117 | Rickets (HP:0002748) | 2.03634284 |
| 118 | Hypoglycemic seizures (HP:0002173) | 2.03221709 |
| 119 | Ulnar claw (HP:0001178) | 2.02800523 |
| 120 | Irritability (HP:0000737) | 2.02401106 |
| 121 | Abnormal eating behavior (HP:0100738) | 2.01546653 |
| 122 | Neonatal onset (HP:0003623) | 2.01086769 |
| 123 | Lymphangioma (HP:0100764) | 1.99323975 |
| 124 | Sleep apnea (HP:0010535) | 1.98845391 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.98063945 |
| 126 | Germ cell neoplasia (HP:0100728) | 1.97688212 |
| 127 | Myocardial infarction (HP:0001658) | 1.97197861 |
| 128 | Generalized tonic-clonic seizures (HP:0002069) | 1.97003296 |
| 129 | Glycosuria (HP:0003076) | 1.96135056 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 1.96135056 |
| 131 | Skin nodule (HP:0200036) | 1.96027336 |
| 132 | Dysmetria (HP:0001310) | 1.95787930 |
| 133 | Abnormality of magnesium homeostasis (HP:0004921) | 1.95272036 |
| 134 | Tetany (HP:0001281) | 1.94267295 |
| 135 | Overriding aorta (HP:0002623) | 1.94092008 |
| 136 | Hemangiomatosis (HP:0007461) | 1.92203373 |
| 137 | Stereotypic behavior (HP:0000733) | 1.91603083 |
| 138 | Apathy (HP:0000741) | 1.91568538 |
| 139 | Torticollis (HP:0000473) | 1.91176368 |
| 140 | Anxiety (HP:0000739) | 1.91138136 |
| 141 | Abnormality of the lower motor neuron (HP:0002366) | 1.90977330 |
| 142 | Mucopolysacchariduria (HP:0008155) | 1.89390883 |
| 143 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89390883 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88484590 |
| 145 | Hyperkalemia (HP:0002153) | 1.87133362 |
| 146 | Abnormality of methionine metabolism (HP:0010901) | 1.86757798 |
| 147 | Vomiting (HP:0002013) | 1.86034844 |
| 148 | Amyloidosis (HP:0011034) | 1.85957780 |
| 149 | Broad face (HP:0000283) | 1.85952996 |
| 150 | Glomerulonephritis (HP:0000099) | 1.85453990 |
| 151 | Megalencephaly (HP:0001355) | 1.84853858 |
| 152 | Lower limb muscle weakness (HP:0007340) | 1.83358723 |
| 153 | Precocious puberty (HP:0000826) | 1.83329841 |
| 154 | Dysmetric saccades (HP:0000641) | 1.81883802 |
| 155 | Elfin facies (HP:0004428) | 1.81418941 |
| 156 | Spinal canal stenosis (HP:0003416) | 1.81354739 |
| 157 | Peripheral hypomyelination (HP:0007182) | 1.80798004 |
| 158 | Poor eye contact (HP:0000817) | 1.80025549 |
| 159 | Postural instability (HP:0002172) | 1.77861810 |
| 160 | Foot dorsiflexor weakness (HP:0009027) | 1.76624984 |
| 161 | Neoplasm of the heart (HP:0100544) | 1.76236490 |
| 162 | Decreased motor nerve conduction velocity (HP:0003431) | 1.75934388 |
| 163 | Lower limb asymmetry (HP:0100559) | 1.73606265 |
| 164 | Hemiplegia (HP:0002301) | 1.69729143 |
| 165 | Epileptiform EEG discharges (HP:0011182) | 1.69441443 |
| 166 | Diminished motivation (HP:0000745) | 1.68698159 |
| 167 | Papilledema (HP:0001085) | 1.68537797 |
| 168 | Distal upper limb amyotrophy (HP:0007149) | 1.68516717 |
| 169 | Upper limb amyotrophy (HP:0009129) | 1.68516717 |
| 170 | Shawl scrotum (HP:0000049) | 1.68449820 |
| 171 | Onion bulb formation (HP:0003383) | 1.67850067 |
| 172 | Urinary urgency (HP:0000012) | 1.66514953 |
| 173 | Hyperparathyroidism (HP:0000843) | 1.66061946 |
| 174 | Renovascular hypertension (HP:0100817) | 1.65714168 |
| 175 | Limb dystonia (HP:0002451) | 1.65518261 |
| 176 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65432463 |
| 177 | Slow progression (HP:0003677) | 1.65264937 |
| 178 | Abnormality of the corticospinal tract (HP:0002492) | 1.63870578 |
| 179 | Incomplete penetrance (HP:0003829) | 1.63562836 |
| 180 | Arterial tortuosity (HP:0005116) | 1.61213079 |
| 181 | Distal sensory impairment (HP:0002936) | 1.61018709 |
| 182 | J-shaped sella turcica (HP:0002680) | 1.59978491 |
| 183 | Impaired social interactions (HP:0000735) | 1.59348669 |
| 184 | Abnormal social behavior (HP:0012433) | 1.59348669 |
| 185 | Termporal pattern (HP:0011008) | 1.58769914 |
| 186 | Insidious onset (HP:0003587) | 1.58769914 |
| 187 | Long toe (HP:0010511) | 1.57940871 |
| 188 | Abnormality of the periventricular white matter (HP:0002518) | 1.57351336 |
| 189 | Mutism (HP:0002300) | 1.57164453 |
| 190 | Nuclear cataract (HP:0100018) | 1.57139696 |
| 191 | Hyperventilation (HP:0002883) | 1.56797399 |
| 192 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.56712719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 2.98001179 |
| 2 | ERN1 | 2.82108154 |
| 3 | SIK1 | 2.80148628 |
| 4 | BCKDK | 2.76054597 |
| 5 | FGFR4 | 2.75025351 |
| 6 | TRIB3 | 2.58825197 |
| 7 | FGFR2 | 2.58761825 |
| 8 | DAPK2 | 2.49692995 |
| 9 | PRKD3 | 2.29689378 |
| 10 | WNK3 | 2.22239867 |
| 11 | OXSR1 | 2.16511093 |
| 12 | TAOK3 | 2.15039243 |
| 13 | EEF2K | 1.98232378 |
| 14 | MST1R | 1.93741401 |
| 15 | MAP3K9 | 1.86639726 |
| 16 | RIPK1 | 1.82280564 |
| 17 | INSRR | 1.80958384 |
| 18 | CASK | 1.79182799 |
| 19 | LATS2 | 1.68164864 |
| 20 | MAP3K2 | 1.66772257 |
| 21 | CAMK1G | 1.64785489 |
| 22 | EPHB1 | 1.62537872 |
| 23 | PTK6 | 1.61470863 |
| 24 | UHMK1 | 1.60730284 |
| 25 | PRPF4B | 1.57491705 |
| 26 | CAMK1D | 1.52593406 |
| 27 | TIE1 | 1.51627889 |
| 28 | MAP2K4 | 1.49470838 |
| 29 | NTRK1 | 1.39047019 |
| 30 | PKN2 | 1.37090743 |
| 31 | TGFBR2 | 1.34958803 |
| 32 | LMTK2 | 1.33278091 |
| 33 | STK39 | 1.28457363 |
| 34 | MAP3K7 | 1.27751023 |
| 35 | MARK1 | 1.26024368 |
| 36 | FRK | 1.21096199 |
| 37 | KSR2 | 1.19260911 |
| 38 | SGK3 | 1.16097415 |
| 39 | TYRO3 | 1.13829229 |
| 40 | LRRK2 | 1.12369559 |
| 41 | STK24 | 1.12252667 |
| 42 | NEK6 | 1.11982216 |
| 43 | CAMK2B | 1.08661452 |
| 44 | RET | 1.07190204 |
| 45 | SGK494 | 1.06322734 |
| 46 | SGK223 | 1.06322734 |
| 47 | MAPK15 | 1.05120261 |
| 48 | TESK1 | 1.03519235 |
| 49 | FER | 1.02397323 |
| 50 | PTK2 | 0.95667252 |
| 51 | JAK1 | 0.93245964 |
| 52 | SMG1 | 0.91396685 |
| 53 | GSK3A | 0.91014372 |
| 54 | STK38 | 0.90354282 |
| 55 | PDPK1 | 0.89166083 |
| 56 | MTOR | 0.88092830 |
| 57 | JAK2 | 0.87299424 |
| 58 | SGK2 | 0.86589974 |
| 59 | ZAP70 | 0.86134086 |
| 60 | PDGFRB | 0.85977882 |
| 61 | PRKCH | 0.84265848 |
| 62 | CDC42BPA | 0.82794620 |
| 63 | EPHA2 | 0.82586593 |
| 64 | FGFR3 | 0.81301384 |
| 65 | CAMKK1 | 0.80689761 |
| 66 | PRKCZ | 0.80536278 |
| 67 | PDGFRA | 0.80326893 |
| 68 | EPHA4 | 0.79234543 |
| 69 | CDK12 | 0.77945728 |
| 70 | MAP3K1 | 0.77497951 |
| 71 | ERBB2 | 0.76950524 |
| 72 | MAPK10 | 0.76769560 |
| 73 | LATS1 | 0.73626477 |
| 74 | ARAF | 0.72705519 |
| 75 | MAP3K4 | 0.72150680 |
| 76 | NTRK3 | 0.70597246 |
| 77 | CDK15 | 0.70527935 |
| 78 | GRK5 | 0.70178568 |
| 79 | CAMK2G | 0.66242458 |
| 80 | CDK18 | 0.65979042 |
| 81 | MET | 0.65364635 |
| 82 | TAOK1 | 0.64635208 |
| 83 | ALK | 0.64345782 |
| 84 | MINK1 | 0.63062009 |
| 85 | CDK11A | 0.60887873 |
| 86 | ROCK2 | 0.60543629 |
| 87 | HIPK2 | 0.60313486 |
| 88 | CAMK1 | 0.59879240 |
| 89 | PHKG2 | 0.59721392 |
| 90 | PHKG1 | 0.59721392 |
| 91 | MAP2K1 | 0.59698831 |
| 92 | TYK2 | 0.59266198 |
| 93 | RPS6KA2 | 0.58628346 |
| 94 | MARK2 | 0.57468688 |
| 95 | EPHA3 | 0.57314376 |
| 96 | PDK1 | 0.57084426 |
| 97 | CDK14 | 0.56427561 |
| 98 | PRKAA2 | 0.55849126 |
| 99 | ICK | 0.55067261 |
| 100 | PRKAA1 | 0.54725387 |
| 101 | PAK3 | 0.54602664 |
| 102 | SIK2 | 0.54082817 |
| 103 | DYRK1A | 0.53966179 |
| 104 | MAP3K3 | 0.53487830 |
| 105 | CAMK2A | 0.53156735 |
| 106 | WNK1 | 0.52966498 |
| 107 | MAPK11 | 0.51573463 |
| 108 | EGFR | 0.49730986 |
| 109 | ERBB4 | 0.49685227 |
| 110 | PKN1 | 0.48433606 |
| 111 | PRKACG | 0.47217627 |
| 112 | DYRK1B | 0.46892162 |
| 113 | MAP3K6 | 0.46815428 |
| 114 | GRK6 | 0.46209311 |
| 115 | MAP3K13 | 0.45714632 |
| 116 | KSR1 | 0.45284731 |
| 117 | EPHB2 | 0.45259010 |
| 118 | ROCK1 | 0.45123297 |
| 119 | STK11 | 0.44752103 |
| 120 | PRKD1 | 0.44638579 |
| 121 | PAK6 | 0.44449600 |
| 122 | PIK3CG | 0.44370045 |
| 123 | CAMK4 | 0.44349577 |
| 124 | PRKCQ | 0.43417258 |
| 125 | MAPK12 | 0.43256761 |
| 126 | BMX | 0.43094340 |
| 127 | CDK5 | 0.43010421 |
| 128 | MAPK8 | 0.42968634 |
| 129 | MAPK13 | 0.42942677 |
| 130 | DAPK1 | 0.42925133 |
| 131 | PRKCG | 0.42397192 |
| 132 | CDK6 | 0.42395117 |
| 133 | NTRK2 | 0.42287425 |
| 134 | RPS6KA3 | 0.41970203 |
| 135 | ABL2 | 0.41754303 |
| 136 | SCYL2 | 0.41715102 |
| 137 | DMPK | 0.41526771 |
| 138 | SGK1 | 0.41490005 |
| 139 | MAP2K2 | 0.40853984 |
| 140 | CSNK1G2 | 0.40267962 |
| 141 | PRKD2 | 0.40208479 |
| 142 | PINK1 | 0.39919229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28025309 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.27210653 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17516115 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66061149 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48604502 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46383200 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45913961 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44503982 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40882104 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37467633 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34038601 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.24481098 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13625989 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.09794016 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04748397 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97488633 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95251604 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95119536 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.93240108 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92889979 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92720437 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.92212236 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87953761 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78914119 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73523547 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69155681 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67987330 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63936554 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63228503 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61754835 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.60550247 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55846712 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.54459268 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47563611 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44801078 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44046714 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40941987 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.40002236 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.36746831 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.36620384 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36546993 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36318439 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31699175 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30965360 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28316554 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28068213 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27373046 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26877809 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.26065491 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26004849 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.22021629 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21017355 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.20107744 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.19945840 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17578958 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.17393598 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16540948 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 1.14832504 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14713539 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14623904 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14236460 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14087044 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11864947 |
| 64 | * ABC transporters_Homo sapiens_hsa02010 | 1.10647828 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09083914 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07721708 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07257847 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06400597 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06229824 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 1.04895274 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04406420 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03567043 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03350907 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02179520 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01830528 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01820015 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01365885 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 1.01273520 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99656031 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99569698 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98626222 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97111775 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94316870 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.93535325 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93100037 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92258038 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92060494 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.91883951 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.89905367 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89415781 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.89200575 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.88705511 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88450662 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86863471 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86475048 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85400211 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84792981 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84226736 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83967008 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83164106 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83099493 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.81643390 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81065668 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79096903 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76143244 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74882760 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74023704 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73772955 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.72520365 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72412888 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71482916 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71354237 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71288639 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71256087 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69581309 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68682023 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67557944 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.64384539 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60990297 |
| 120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59947267 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58926395 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57249676 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57139702 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.57040027 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56860585 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56028087 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55860039 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55280684 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55180263 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54027970 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51600024 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48954246 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48743315 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48701016 |
| 135 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48103655 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47928240 |
| 137 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47428894 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47368671 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47268824 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46506072 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46447976 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46027116 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42802484 |
| 144 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40166561 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.36031076 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34263232 |
| 147 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33011355 |
| 148 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30899193 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30659381 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30420863 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28860348 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28205668 |
| 153 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26551726 |
| 154 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24892703 |
| 155 | Salivary secretion_Homo sapiens_hsa04970 | 0.23665456 |
| 156 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23097033 |
| 157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22388096 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22358496 |
| 159 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21728758 |
| 160 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21445953 |
| 161 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21079821 |
| 162 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20888121 |
| 163 | Insulin secretion_Homo sapiens_hsa04911 | 0.20065015 |
| 164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17761981 |
| 165 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17155696 |
| 166 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17130561 |
| 167 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13658921 |
| 168 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13275746 |
| 169 | Renin secretion_Homo sapiens_hsa04924 | 0.12623139 |
| 170 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12456669 |
| 171 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10670737 |
| 172 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09521585 |
| 173 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09128090 |

